# ImClone Systems, LLC, Branchburg, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/imclone-systems-llc/ccde4edf-e0cb-4367-a935-725ce0bad4d3

> Inspection records and compliance data for ImClone Systems, LLC in Branchburg, New Jersey. 11 FDA inspections on record (2 OAI), 2 Form 483s, last inspected July 27, 2023.

---

## Details

- Name: ImClone Systems, LLC
- FEI Number: 3002889358
- Facility Type: Biological Drug Substance Manufacturer
- Address Line 1: 33 Imclone Dr
- City: Branchburg
- State: New Jersey
- Zip Code: 08876
- Country Name: United States
- Address: 33 Imclone Dr, Branchburg, New Jersey 08876, United States
- Country: United States

## Related Documents

- [483 - ImClone Systems, LLC - 2023-07-27](https://www.keypedia.com/records/483/imclone-systems-llc/b5b6a98b-9535-4ecf-a99b-1f3057cdae86) — source: FDA, date: July 27, 2023
- [FDA Inspection 1217252 - ImClone Systems, LLC - 2023-07-27](https://www.keypedia.com/records/fda_inspections/imclone-systems-llc/da41ad9e-55f0-4f87-9cc1-a4daba7542d6) — source: FDA, date: July 27, 2023
- [FDA Inspection 1178892 - ImClone Systems, LLC - 2022-08-25](https://www.keypedia.com/records/fda_inspections/imclone-systems-llc/4ca8d2a4-1cd8-4a23-a59b-461a86132b5e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 25, 2022
- [483 - ImClone Systems, LLC - 2022-08-22](https://www.keypedia.com/records/483/imclone-systems-llc/c62fe083-c70c-44f1-8d2f-aa5dfcaf28a3) — source: FDA, date: August 22, 2022
- [483 - ImClone Systems, LLC - 2020-08-21](https://www.keypedia.com/records/483/imclone-systems-llc/db44c46a-32b3-4767-929a-56d701d813ae) — source: FDA, date: August 21, 2020
- [FDA Inspection 1128945 - ImClone Systems, LLC - 2020-08-21](https://www.keypedia.com/records/fda_inspections/imclone-systems-llc/f5401227-bedc-4f92-9ecb-2efa660cae48) — classification: Official Action Indicated (OAI), source: FDA, date: August 21, 2020
- [483 - ImClone Systems, LLC - 2019-11-26](https://www.keypedia.com/records/483/imclone-systems-llc/ae1b1bac-061f-4570-b184-9b382ec3c67f) — source: FDA, date: November 26, 2019
- [FDA Inspection 1111276 - ImClone Systems, LLC - 2019-11-26](https://www.keypedia.com/records/fda_inspections/imclone-systems-llc/0ee54811-983a-45a9-a6f3-43b7ec934dda) — classification: Official Action Indicated (OAI), source: FDA, date: November 26, 2019
- [483 - ImClone Systems, LLC - 2018-03-09](https://www.keypedia.com/records/483/imclone-systems-llc/15bc1098-5ad2-4372-9bdf-209468afb7a5) — source: FDA, date: March 9, 2018
- [FDA Inspection 1043915 - ImClone Systems, LLC - 2018-03-09](https://www.keypedia.com/records/fda_inspections/imclone-systems-llc/05c601b8-2c85-43f1-810b-91f6047f862c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2018
- [EIR - ImClone Systems, LLC - 2017-09-21](https://www.keypedia.com/records/eir/imclone-systems-llc/56c42bf4-2c5d-48f6-a79a-841939a13c0b) — source: FDA, date: September 21, 2017
- FDA Inspection 1029810 - ImClone Systems, LLC - 2017-09-21 — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2017
- [EIR - ImClone Systems, LLC - 2015-07-10](https://www.keypedia.com/records/eir/imclone-systems-llc/783c5945-39b5-4aa5-a271-b36bbe7e834d) — source: FDA, date: July 10, 2015
- FDA Inspection 933959 - ImClone Systems, LLC - 2015-07-10 — classification: No Action Indicated (NAI), source: FDA, date: July 10, 2015
- FDA Inspection 856113 - ImClone Systems, LLC - 2013-11-13 — classification: No Action Indicated (NAI), source: FDA, date: November 13, 2013
- FDA Inspection 810161 - ImClone Systems, LLC - 2012-12-11 — classification: No Action Indicated (NAI), source: FDA, date: December 11, 2012
- FDA Inspection 747073 - ImClone Systems, LLC - 2011-09-28 — classification: No Action Indicated (NAI), source: FDA, date: September 28, 2011

## Related Companies

- [Agilent Technologies Inc](https://www.keypedia.com/companies/agilent-technologies-inc/865fe026-9db0-4e3e-bc4a-e0d25b465093)
- [Biocon Limited](https://www.keypedia.com/companies/biocon-limited/7b8920c7-f5be-4f17-8100-3bede3943790)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [MSN Laboratories Private Limited, Unit-II](https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a)
- [Biocon Biosphere Limited](https://www.keypedia.com/companies/biocon-biosphere-limited/4c5f824e-c399-4c0e-91be-45739741dc2c)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Ercros S.A.](https://www.keypedia.com/companies/ercros-sa/adeb63ee-2821-47de-939a-39c363e39854)
- [Cipla Ltd.](https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82)
- [QOL Medical LLC](https://www.keypedia.com/companies/qol-medical-llc/83e2d372-ec27-4388-ab26-9774d5edcc55)

## Related Officers

- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)
- [Investigator](https://www.keypedia.com/people/michael-r-klapal/b181b5e8-4fc3-48ed-b17c-791359e7b619)
- [Russell J. Glapion](https://www.keypedia.com/people/russell-j-glapion/54dd6274-563a-44fe-8016-2ebd700be7a0)
- [recipient](https://www.keypedia.com/people/victor-m-cruz/c8c2f9c5-f2b6-4e21-980f-8c5eb5e96879)
- [Nailing Zhang](https://www.keypedia.com/people/nailing-zhang/d3814d08-b799-4de1-b901-1b90da0e0178)
- [recipient](https://www.keypedia.com/people/yan-wang/9152655d-5458-4869-8e15-3227cec56699)